AzTrials
AzTrials

StrokeNCT07340034

Effects of Focal Muscle Vibration Versus Whole Upper Limb Vibration in Post-Stroke Patients

A study testing Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitation and Upper limb vibration through whole body vibrator along with conventional neurorehabilitation in people with Stroke and Post Stroke Upper Limb Spasticity, run by Lahore University of Biological and Applied Sciences at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This study contributes to the growing body of knowledge on rehabilitation strategies for post-stroke patients, specifically focusing on the efficacy of vibration therapy modalities. Read more about this study

Who is it for?
Ages 45 to 60 years
Conditions the study is for
Stroke, Post Stroke Upper Limb Spasticity
What is being tested?
Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitation and Upper limb vibration through whole body vibrator along with conventional neurorehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 sitePakistan
Study dates
21 Apr 2026to 9 Jul 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Clinical diagnosis of first-ever ischemic stroke
  • Age from 45 to 60 years
  • Both male and female participants
  • Onset of stroke 3 month to 6 months previously
  • Modified Ashworth Scale (MAS) score for the upper limb muscles on the hemiparetic side between 1+ and 3
  • Able to follow verbal commands and sign informed consent forms EXCLUSION CRITERIA
Show all 13Show fewer
  • Cardiovascular disease or uncontrolled diabetes
  • Upper limb muscle contracture on the affected side
  • Peripheral neuropathy
  • Uncontrolled hypertension
  • Malignant tumors
  • Uncontrolled seizures
  • Dementia

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Shadman Medical Center, Stroke Rehabilitation Center

    Lahore, Punjab Province, 54000

Other trials in Pakistan

About this study

Official title: Effects of Focal Muscle Vibration Versus Whole Upper Limb Vibration on Spasticity and Upper Motor Control Functions in Post-Stroke Patients

This study contributes to the growing body of knowledge on rehabilitation strategies for post-stroke patients, specifically focusing on the efficacy of vibration therapy modalities. By comparing focal muscle vibration therapy and whole upper limb vibration therapy, the research aims to provide empirical evidence that can inform clinical practices and enhance rehabilitation outcomes. The findings are expected to clarify which modality is more effective in reducing spasticity and improving motor control, thereby guiding clinicians in selecting appropriate interventions tailored to individual patient needs, increasing chances of benefits, time management and useful for academic purpose. Furthermore, the study addresses a critical gap in the literature, facilitating further research and discussion on the mechanisms underlying vibration therapy's effects.

Ultimately, this research aims to reduce spasticity and improve community outcomes by enhancing the quality of life for stroke survivors, enabling them to regain independence and participate more fully in daily activities by regaining the motor control functions. By contributing to both theoretical and practical frameworks, the study seeks to advance the field of neurorehabilitation and support informed decision-making among healthcare professionals.

Read the detailed description

Motor impairment post-stroke, which usually affects the movement of the face, arm, and leg on one side of the body, impacts approximately 80% of individuals who have experienced a stroke. Upper limb motor impairments (involving the arm, hand, and/or fingers) are often long-lasting and debilitating; only about half of stroke survivors with an initially paralyzed upper limb recover some useful function within six months.

Recently, mechanical vibrations have been utilized as a form of somatosensory stimulation to enhance motor function and to address muscle spasticity in the upper limbs following a stroke. When applying vibration stimuli during exercise or physical rehabilitation, these can be broadly classified into two categories: (a) vibrations that are directly applied to a specific muscle or tendon, and (b) indirect vibrations that are not limited to a specific muscle, delivered either through the feet while standing on a platform or through the hands using a handheld device. The direct application of vibrations to a muscle or tendon is often referred to as focal muscle vibration (FMV) or segmental vibration (SV), and it may also be called repetitive muscle vibration (rMV). In contrast, indirect vibrations delivered through the hands are typically known as upper limb vibration (ULV), while those aimed at the lower limbs are referred to as whole-body vibration (WBV).

Vibration therapy (VT) is a form of physical therapy that employs mechanical vibration waves to stimulate the human neuromuscular system for therapeutic benefits. It demonstrates promising potential for use in the rehabilitation of dysfunctions part of bosy resulting from a stroke.

Focal muscle vibration (FMV) OR segmental muscle vibration is a relatively new approach used to enhance motor function and reduce spasticity in the hemiplegic upper limb of stroke patients. In FMV, a vibratory stimulus is delivered to a specific muscle tendon via a mechanical device, which activates the muscle spindle primary endings and generates Ia inputs. Vibration applied to a muscle can elevate the motor-evoked potential recorded from that muscle at rest, indicating an increase in corticospinal excitability during the vibration. Additionally, studies have shown that the duration of the cortical silent period in a forearm flexor muscle can increase when the antagonist forearm extensors are vibrated, providing strong evidence that pure sensory stimulation can influence motor cortical excitability.

Being tested
Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitation, Upper limb vibration through whole body vibrator along with conventional neurorehabilitation
Keywords
Whole upper limb vibration, Focal muscle vibration, Upper limb spasticity, Upper Motor Control Functions
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitationOther

    Group A will receive the 30 minutes treatment protocol. Warm-up exercises for first 15 minutes with ROM and stretching exercises of upper extremity 15 minutes application of FMV All participants were instructed to sit back in a high, fixed chair without armrests, keeping their feet flat on the floor. The dominant shoulder was positioned slightly away from the trunk i.e. in slight abduction and the elbow was held at a 90° angle as part of the designated vibration position. After setting up, the researcher guided the participants to remain seated in the same position as it might affect the results and treatment. The participants then received the vibration in frequency of 30 Hz in both vertical and horizontal directions.

    Based on our review of prior clinical studies aimed at improving muscle spasticity we implemented vibration protocols with exposure times ranging from 30 to 60 seconds and rest intervals between 15 and 60 seconds. The analysis focused on seven muscle groups

  • Upper limb vibration through whole body vibrator along with conventional neurorehabilitationOther

    Group B will receive the 30 minutes treatment protocol. Warm-up exercises for first 15 minutes with ROM and stretching exercises of upper extremity.

    Patients in the treatment group received upper limb vibration using the Power Plate vibration platform (Performance Health Systems, Power Plate Pro5, North America 2009). The patient was seated on a stool placed next to the whole-body vibration device; the elbow was positioned at 70-80 degrees flexion and wrist was positioned at dorsiflexion and upper limb vibration was applied through Whole body vibrator to the affected limb for two minutes. The WBV consisted of two sessions of 60 seconds of stimulation interrupted by a one-minute break between each session to prevent muscle fatigue. The amplitude of the vibration was 2 mm, and the frequency was 35-40 Hz. An experienced physical therapist supervised the WBV administration. The upper limb vibration treatment was performed 5 times a week for 8 weeks.

Study groups in NCT07340034
Study groupRoleWhat they receive
Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitationExperimentalGroup A will receive the Focal muscle vibration in the major group of muscle such as Elbow flexors and wrist flexors along with the conventional neurorehabilitation.
Receives: Other: Focal muscle vibration through focal muscle vibrator along with conventional neurorehabilitation
Upper limb vibration through whole body vibrator along with conventional neurorehabilitationActive comparatorGroup B will receive the upper limb vibration which will include all muscles of effected limb along with the conventional neurorehabilitation.
Receives: Other: Upper limb vibration through whole body vibrator along with conventional neurorehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer assessment of upper limb (FMA-UE)

    The Fugl-Meyer Assessment-Upper Extremity (FMA-UE) is a commonly utilized tool for measuring motor impairment in stroke rehabilitation. The FMA-UE has demonstrated excellent test-retest and inter- and intra-rater reliability, and evidence for its content validity in acute and subacute populations have been widely reported. The UE section of the FMA consists of 33 items and is scored on a 3-point ordinal scale with 0 meaning cannot perform, 1 meaning can partially perform, and 2 meaning can perform fully. Scores are summed with a maximum potential score of 66 points.

    Measured: baseline, after 2 weeks and 4 weeks

  2. Modified Ashworth scale (MAS)

    The Modified Ashworth Scale (MAS) is the most widely used clinical tool for measuring increased muscle tone or spasticity The MAS has demonstrated excellent test-retest and inter- and intra-rater reliability, The inter-rater reliability of the scale has been reported to vary significantly depending on the muscle group being assessed, the examiner's experience, and methodological inconsistencies in applying the scale.

    The scale is as follows:

    0: No increase in muscle tone

    1. Slight increase in muscle tone, with a catch and release or minimal resistance at the end of the range of motion when an affected part(s) is moved in flexion or extension 1+: Slight increase in muscle tone, manifested as a catch, followed by minimal resistance through the remainder (less than half) of the range of motion
    2. A marked increase in muscle tone throughout most of the range of motion
    3. Considerable increase in muscle tone, passive movement difficult
    4. Affected part(s) rigid in flexion or extension

    Measured: baseline, after 4 weeks and 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2026
  2. Study start21 Apr 2026
  3. Primary completion9 Jul 2026
  4. Study completion9 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study will use a parallel-group design, with participants randomly allocated into two intervention groups. Group A (Focused Muscle Vibration - FMV) 30-minute session: 15 min upper-extremity ROM/stretching + 15 min FMV. FMV delivered at 30 Hz while seated (shoulder slightly abducted, elbow at 90°). Vibration applied in 60-s bouts with 60-s rest. Target muscles: biceps, triceps, anterior deltoid, FDS, FCR, ECR, ECU. Frequency: 5 days/week for 8 weeks. Group B (Upper Limb Vibration ULV) 30-minute session: 15 min ROM/stretching + ULV using Power Plate Pro5. Seated position with elbow 70-80° flexion and wrist dorsiflexed. ULV applied in 2 × 60-s bouts, 1-min rest, amplitude 2 mm, frequency 35-40 Hz. Frequency: 5 days/week for 8 weeks. Participants will be randomly allocated into two parallel groups to ensure an unbiased comparison, with each group receiving its specific intervention protocol throughout the study period without crossover to the other groups intervention.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07340034
Sponsor's protocol ID
UBAS/ERB/FoRS/25/036
Status last verified
Jul 2026
First submitted
5 Jan 2026
Last updated
24 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lu YH, Chen HJ, Liao CD, Chen PJ, Wang XM, Yu CH, Chen PY, Lin CH. Upper extremity function and disability recovery with vibration therapy after stroke: a systematic review and meta-analysis of RCTs. J Neuroeng Rehabil. 2024 Dec 21;21(1):221. doi: 10.1186/s12984-024-01515-6.

    PubMed 39707380
  • Karnath HO. Pusher syndrome--a frequent but little-known disturbance of body orientation perception. J Neurol. 2007 Apr;254(4):415-24. doi: 10.1007/s00415-006-0341-6. Epub 2007 Mar 25.

    PubMed 17385082

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in